Potential growth inhibitory effect of maitake D-fraction on canine cancer cells

Veterinary Therapeutics

Volumn 5, Issue 4, 2004, Pages

  Konno, Sensuke ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BASIDIOMYCOTA; GRIFOLA FRONDOSA;

EID: 79251489486     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Nanba H, Hamaguchi A, Kuroda H: The chemical structure of an antitumor polysaccharide in fruit bodies of Grifola frondosa (maitake). Chem Pharm Bull 35:1162-1168, 1987.
2. Kabir Y, Yamaguchi M, Kimura S: Effect of shiitake and maitake mushrooms on blood pressure and plasma lipids of spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 33:341-346, 1987.
3. Adachi K, Nanba H, Otsuka M, et al: Blood pressure-lowering activity present in the fruit body of Grifola frondosa (maitake). Chem Pharm Bull 36:1000-1006, 1988.
4. Kubo K, Aoki H, Nanba H: Anti-diabetic activity present in the fruit body of Grifola frondosa (maitake). Biol Pharm Bull 17:1106-1110, 1994.
5. Kubo K, Nanba H: The effect of maitake mushroom on liver and serum lipids. Altern Ther Health Med 2:62-66, 1996.
6. Jones K: Maitake, a potent medicinal food. Alt Complement Ther 4:420-429, 1998.
7. Nakai R, Masui H, Horio H, et al: Effect of maitake (Grifola frondosa) water extract on inhibition of adipocyte conversion of C3H10T1/2B2C1 cells. J Nutr Sci Vitaminol (Tokyo) 45:385-389, 1999.
8. Wu S, Zou D, Han SH, et al: Therapeutic effect of Grifola polysaccharides in chronic hepatitis B, in: International Symposium on Production and Products of Lentinus Mushroom, Programme and Abstracts. Qingyuan, China, November 1-3, 1994.
9. Developmental Therapeutics Program, National Cancer Institute: In-vitro Anti-HIV Drug Screening Results. Washington, DC, National Science Council F195001, January 1992.
10. Mizuno T, Zhuang C: Maitake (Grifola frondosa): Pharmacological effects. Food Rev Int 11:135-149, 1995.
11. Hishida I, Nanba H, Kuroda H: Antitumor activity exhibited by orally administered extract from fruit body of Grifola frondosa (maitake). Chem Pharm Bull 36:1819-1827, 1988.
12. Nanba H: Antitumor activity of orally administered D-fraction from maitake mushroom. J Naturopathic Med 1:10-15, 1993.
13. Nanba H: Maitake D-fraction: Healing and preventive potential for cancer. J Orthomol Med 12:43-49, 1997. (Pubitemid 27217361)
14. Nanba H: Results of non-controlled clinical study for various cancer patients using maitake D-fraction. Explore 6:19-21, 1995.
15. Maitake Products, Inc: Maitake D-fraction Obtained IND for Clinical Study [corporate publication]. Paramus, NJ, February 1998.
16. Fullerton SA, Samadi AA, Tortorelis DG, et al: Induction of apoptosis in human prostatic cancer cells with b-glucan (maitake mushroom polysaccharide). Mol Urol 4:7-11, 2000.
17. Finkelstein MP, Aynehchi S, Samadi AA, et al: Chemosensitization of carmustine with maitake b-glucan on androgen-independent prostatic cancer cells: Involvement of glyoxalase I. J Altern Complement Med 8:573-580, 2002.
18. Momoi Y, Okai Y, Watari T, et al: Establishment and characterization of a canine T-lymphoblastoid cell line derived from malignant lymphoma. Vet Immunol Immunopathol 59:11-20, 1997.
19. Nakayama GR, Caton MC, Nova MP, Parandoosh Z: Assessment of the alamarBlue assay for cellular growth and viability in vitro. J Immunol Methods 204:205-208, 1997.
20. Japan Food Research Laboratories: Test of Maitake D-Fraction for Acute Oral Toxicity in Mice. Report No. 203100558-002. Tokyo, November 2003.